In the fall of last year, Amazon launched online pharmaceutical services, Amazon Pharmacy. According to the Amazon Pharmacy website, the services are available for customers over the age of 18. The customer has to create a separate account for Amazon Pharmacy. It should be noted that Prime savings can be applied at Amazon Pharmacy as well.
The high demand for automation in liquid handling is the key factor driving market growth in this segment. Automated workstations offer advantages such as enhanced accuracy, and reduced time and cost. According to a new market research report the market is expected to reach $5.20 Billion by 2022 from an estimated $4.06 Billion in 2017, at a CAGR of 5.1%.
The N-Hexyl alcohol market size has been segmented, by region, into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.Asia-Pacific accounted for the majority share of the N-hexyl alcohol market in 2017; the regional market is likely to witness significant growth during the review period.
Russian scientists from the Far Eastern Federal University have developed a hydrogel that can be used to restore the nervous tissue of the brain after damage. The new product is also useful for fighting malignant tumors and targeted drug delivery. Russian scientists have developed a hydrogel that can be used as an artificial matrix.
This week, the news of Russia developing a vaccine against Coronavirus made world news. Currently, there over 20.7 million cases of the infected and over 749,000 deaths around the globe. According Russian President Vladimir Putin, “the vaccine forms a stable immune system,” and “passed all the necessary checks.”
Coronavirus continues to be on the news. Currently, there are over 19 million infected and over 700,000 dead around the globe. Hence, the need for the treatment and vaccine continues to be the top priority. Many countries continue to see the rise in numbers. The US had one of the largest number increases in the world.
South Korean Engineers from the Korea Institute of Machinery and Materials have created a robot that can help fight the coronavirus. The robot allows a doctor to take an analysis from a patient without coming into contact with them. This technology can protect medical professionals against infection from dangerous diseases.
Scientists from the USA, Russia, and Germany made a great discovery that antibiotic-resistant pathogens are defenseless against a long-known substance. This discovery may become the basis for the development of new effective drugs. There is a need for a new class of drugs, since antibiotic resistance is on the rise.
As of April 7th, there are over 1,390,511 infected cases of coronavirus around the world according to the John Hopkins interactive tool. Thus far there haven’t been any drugs to specifically treat coronavirus. Many doctors around the world are trying to treat infected with anti-malaria drugs and also AIDS drugs. The same protocols were used during SARS.
A new material has been developed in Russia that will allow drugs to be transported to affected cells and will allow people to perform DNA testing at home. The abstract has been published in ACS Publication titled “Nanoparticle Beacons: Supersensitive Smart Materials with On/Off-Switchable Affinity to Biomedical Targets.” The discovery was led by Maxim Nikitin from The Moscow Institute of Physics, and Technology (MIPT), known informally as PhysTech, a Russian university originally established in the Soviet Union. It prepares specialists in theoretical and applied physics, applied mathematics and related disciplines. MIPT is known for specifics of the MIPT educational process.
Market Research Future (MRFR) announces the publication of its research report Global Flavanones Market, 2017–2024. Flavanones are colorless flavonoids derived from flavones that exist as glycosides in citrus plants.
The industrial filtration market is expected to grow from an estimated $25.89 billion in 2018 to $35.47 billion by 2023, registering a CAGR of 6.50% during the forecast period. This growth is primarily due to the growing industrialization and urbanization, stringent regulations pertaining to emissions and treatment of industrial waste, and requirement of safe working environment in industrial facilities.
On Tuesday, Pakistan announced a lifting of the ban on imports of life-saving drugs from India. With the approval of the Federal Government, the Ministry of Commerce has issued a notification for amending the Export-Import Order 2016, under which Pakistan will now be able to import life-saving medicines from India and export to India.
Following the approval of the first monoclonal antibody in 1986, the approval and sales were flat until the introduction of the first chimeric monoclonal antibodies. Further approvals of humanized and fully human monoclonal antibodies, the market for therapeutic monoclonal antibodies experienced a significant surge to become a multi-billion dollar market in the current decade.
The demand for flexible packaging especially that made of biodegradable material is highly in demand today. People are preferring the use of sustainable products for packaging. The packaging industry is also witnessing the introduction of new and innovative packaging types for various applications in the food and pharmaceuticals industries.
This week, Durig Capital looks to the healthcare sector where a specialty pharmaceutical company has posted solid back-to-back quarters resulting in increased guidance for 2018. As a result of Mallinckrodt Pharmaceuticals’ performance in both Q1 and Q2, company management has raised 2018 guidance citing solid performance across its product lines. Some of the highlights from Mallinckrodt’s Q2 numbers include:
Q2 cash flows from operating activities grew by 17.6% over the same period last year.
Net sales increased 5.3% year-over-year.
Adjusted Gross Profit increased by 8.4%
Year-to-date debt reduction of $535.2 million
Interest coverage over 2x for the first six months of 2018.